New Delhi, Dec 29: Serum Institute of India has already produced around 50 million dosages of the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' and plans to scale it up to 100 million by March next year even as it awaits approval for emergency
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2KyJW9X
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2KyJW9X
ConversionConversion EmoticonEmoticon